|
Oct 14
|
Is Carl Zeiss Meditec AG's (ETR:AFX) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
|
|
Oct 9
|
ZEISS expands ophthalmic offerings to improve patient care with new digital AI tools and revolutionary surgical solutions
|
|
Aug 29
|
ZEISS innovation paves way to more personalized patient care with cutting-edge AI technology and industry-leading surgical solutions
|
|
Apr 4
|
Carl Zeiss Meditec AG Completes Acquisition of Dutch Ophthalmic Research Center (D.O.R.C.); Companies Unite to Shape Ophthalmology Market
|
|
Mar 28
|
ZEISS Sets Stage for Future of Ophthalmic Surgery and 3D Visualization at ASCRS 2024
|
|
Mar 25
|
Carl Zeiss Meditec's (ETR:AFX) investors will be pleased with their respectable 63% return over the last five years
|
|
Jan 11
|
U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS
|
|
Dec 19
|
Carl Zeiss Meditec Full Year 2023 Earnings: EPS Beats Expectations
|
|
Nov 27
|
Are Strong Financial Prospects The Force That Is Driving The Momentum In Carl Zeiss Meditec AG's ETR:AFX) Stock?
|
|
Jul 18
|
Do Carl Zeiss Meditec's (ETR:AFX) Earnings Warrant Your Attention?
|